Scholarly Index
Enrique Grande
Hospital Universitario Quirónsalud Madrid; 12,781 total citations; 419 total publications; best world rank #44
Hospital Universitario Quirónsalud Madrid
12,781Total citations
419Total publications
48H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neuroendocrine Tumor Research Advances | Lifetime | 647 | ES 8 | 97.90 |
| Lung Cancer Research Studies | Lifetime | 658 | ES 14 | 97.78 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 665 | ES 16 | 97.53 |
| Neuroblastoma Research and Treatments | Lifetime | 580 | ES 7 | 97.09 |
| Renal cell carcinoma treatment | Lifetime | 952 | ES 15 | 96.46 |
| Urinary and Genital Oncology Studies | Lifetime | 546 | ES 15 | 96.59 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 923 | ES 12 | 95.50 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 44 | ES 4 | 98.38 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 75 | ES 3 | 98.84 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 422 | ES 17 | 98.34 |
| Neuroblastoma Research and Treatments | 2021-2025 | 72 | ES 5 | 97.00 |
| Lung Cancer Research Studies | 2021-2025 | 181 | ES 9 | 97.64 |
| Urinary and Genital Oncology Studies | 2021-2025 | 97 | ES 4 | 97.51 |
| Renal cell carcinoma treatment | 2021-2025 | 264 | ES 6 | 95.71 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 106 | ES 3 | 90.70 |
| Renal and related cancers | 2021-2025 | 670 | ES 13 | 84.89 |